About Arpeggio
Arpeggio is a company based in Boulder (United States) founded in 2017 by Laura Norris and Joey Azofeifa.. Arpeggio has raised $49.48 million across 5 funding rounds from investors including Tencent, FundersClub and Khosla Ventures. The company has 8 employees as of December 31, 2021. Arpeggio offers products and services including Transcriptomic Platform and Drug Programs. Arpeggio operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BridgeBio, BeiGene and Advanced Accelerator Applications, among others.
- Headquarter Boulder, United States
- Employees 8 as on 31 Dec, 2021
- Founders Laura Norris, Joey Azofeifa
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Arpeggio Biosciences Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$49.48 M (USD)
in 5 rounds
-
Latest Funding Round
$20.04 M (USD), Series B
Nov 12, 2025
-
Investors
Tencent
& 13 more
-
Employee Count
8
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Arpeggio
Arpeggio offers a comprehensive portfolio of products and services, including Transcriptomic Platform and Drug Programs. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for rapid transcriptomic sequencing to map chemistry to biology networks.
Programs targeting drug resistance in cancer and chronic diseases.
Unlock access to complete
Unlock access to complete
Funding Insights of Arpeggio
Arpeggio has successfully raised a total of $49.48M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $20.04 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series B — $20.0M
-
First Round
First Round
(16 Aug 2019)
- Investors Count 14
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2025 | Amount | Series B - Arpeggio | Valuation |
investors |
|
| Mar, 2025 | Amount | Series A - Arpeggio | Valuation |
investors |
|
| Aug, 2022 | Amount | Series A - Arpeggio | Valuation | Builders VC |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Arpeggio
Arpeggio has secured backing from 14 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Tencent, FundersClub and Khosla Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in technologies that modernize industries like agriculture and construction.
|
Founded Year | Domain | Location | |
|
Early-stage startups are funded by this venture capital firm.
|
Founded Year | Domain | Location | |
|
TechU Ventures is involved in unspecified technology ventures.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Arpeggio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Arpeggio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Arpeggio Comparisons
Competitors of Arpeggio
Arpeggio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BridgeBio, BeiGene and Advanced Accelerator Applications, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Arpeggio
Frequently Asked Questions about Arpeggio
When was Arpeggio founded?
Arpeggio was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Where is Arpeggio located?
Arpeggio is headquartered in Boulder, United States. It is registered at Boulder, Colorado, United States.
Is Arpeggio a funded company?
Arpeggio is a funded company, having raised a total of $49.48M across 5 funding rounds to date. The company's 1st funding round was a Series A of $20.25M, raised on Aug 16, 2019.
How many employees does Arpeggio have?
As of Dec 31, 2021, the latest employee count at Arpeggio is 8.
What does Arpeggio do?
Arpeggio was founded in 2017 and is based in Boulder, United States. A drug discovery platform is offered in the biotechnology sector, where DNA sequencing and CRISPR-based screening are utilized to identify therapeutic targets and biomarkers for cancer. Drug candidates are being developed for sarcomas, lung adenocarcinoma, and autoimmune diseases, with operations focused on advancing precision medicine approaches.
Who are the top competitors of Arpeggio?
Arpeggio's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
What products or services does Arpeggio offer?
Arpeggio offers Transcriptomic Platform and Drug Programs.
Who are Arpeggio's investors?
Arpeggio has 14 investors. Key investors include Tencent, FundersClub, Khosla Ventures, Builders VC, and TechU Ventures.